D05.99 Unspecified carcinoma in situ of unspecified breast

Name of the Condition

• Unspecified carcinoma in situ of unspecified breast
• Often referred to as "in situ breast carcinoma" or "non-invasive breast cancer."

Summary

Carcinoma in situ of the breast refers to a group of abnormal cells that remain in the place where they first formed and have not spread to nearby breast tissue. It is considered the earliest form of breast cancer and typically does not cause symptoms.

Causes

Genetic mutations affecting cell growth regulation, hormonal influences, and certain lifestyle factors may contribute to the development of this condition.

Risk Factors

Advancing age, particularly post-menopausal women; family history of breast cancer; genetic mutations in BRCA1 or BRCA2 genes; prior history of breast conditions like atypical hyperplasia.

Symptoms

Usually asymptomatic and often detected through routine mammograms. Occasionally, a small, localized lump may be felt.

Diagnosis

Mammography is the primary screening tool. Breast ultrasound or MRI may provide additional information. Biopsy through fine-needle aspiration, core needle, or surgical biopsy confirms diagnosis.

Treatment Options

• Surgery: Lumpectomy (removal of the tumor and some surrounding tissue) or mastectomy (removal of one or both breasts) to eliminate abnormal cells.
• Radiation Therapy: Often recommended after lumpectomy to reduce recurrence risk.
• Hormone Therapy: May be used if the cancer is hormone receptor-positive to block estrogen or progesterone effects.

Prognosis and Follow-Up

Prognosis is generally favorable with early detection and treatment. Regular follow-up, including mammograms and clinical exams, is essential to monitor for recurrence.

Complications

If left untreated, carcinoma in situ may progress to invasive breast cancer. Treatment side effects may include infection, scarring, or lymphedema.

Lifestyle & Prevention

Maintaining a healthy weight, limiting alcohol intake, and regular physical activity may help reduce risk. Discuss screening guidelines with a healthcare provider.

When to Seek Professional Help

Consult a healthcare provider if a new lump is detected, or if there are changes in breast appearance or texture. Routine screenings are recommended for early detection.

Tips for Medical Coders

Use this code for unspecified carcinoma in situ of the breast when the specific type or laterality is not documented. Ensure documentation supports the absence of invasive spread. Verify that the code aligns with clinical findings and provider notes.